Ally Bridge Group (Ny) LLC Merus N.V. Transaction History
Ally Bridge Group (Ny) LLC
- $114 Million
- Q1 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Merus N.V. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 255,928 shares of MRUS stock, worth $13.6 Million. This represents 10.14% of its overall portfolio holdings.
Number of Shares
255,928
Previous 274,923
6.91%
Holding current value
$13.6 Million
Previous $7.56 Million
52.43%
% of portfolio
10.14%
Previous 6.47%
Shares
5 transactions
Others Institutions Holding MRUS
# of Institutions
164Shares Held
47.9MCall Options Held
123KPut Options Held
293K-
Commodore Capital LP New York, NY4.36MShares$231 Million16.96% of portfolio
-
Rtw Investments, LP New York, NY4.11MShares$218 Million2.97% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.65MShares$141 Million2.46% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.25MShares$119 Million0.24% of portfolio
-
Samlyn Capital, LLC New York, NY2.08MShares$110 Million1.66% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.44B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...